Koyfin Home > Directory > Health Care > Akebia Therapeutics > Issuance of Common Stock

Akebia Therapeutics Issuance of Common Stock Chart (AKBA)

Akebia Therapeutics annual/quarterly Issuance of Common Stock from 2013 to 2020.
  • Akebia Therapeutics Issuance of Common Stock for the quarter ending June 06, 2020 was $143m a 99.86% increase of 143m year over year
  • Akebia Therapeutics Issuance of Common Stock for the last 12 months ending June 06, 2020 was $217m a 95.36% increase of 207m year over year
  • Akebia Therapeutics Annual Issuance of Common Stock for 2019 was $27m a -261.35% decrease of -70m from 2018
  • Akebia Therapeutics Annual Issuance of Common Stock for 2018 was $97m a -20.36% decrease of -20m from 2017
  • Akebia Therapeutics Annual Issuance of Common Stock for 2017 was $116m a 42.39% increase of 49m from 2016
Other Cash Flow Metrics:
  • Akebia Therapeutics Cash Flow from Operations for the quarter ending December 12, 2018 was $-74m a 72.41% decrease of -53m year over year
  • Akebia Therapeutics Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-92m a 89.67% decrease of -82m year over year
  • Akebia Therapeutics Total Revenue for the quarter ending December 12, 2018 was $60m a 23.26% increase of 14m year over year
View Chart On Koyfin

Quarterly AKBA Issuance of Common Stock Data

06/2020$143m
03/2020$57m
12/2019$17m
09/2019$0m
06/2019$9m
03/2019$1m
12/2018$0m
09/2018$0m
06/2018$0m
03/2018$96m

Annual AKBA Issuance of Common Stock Data

2019$27m
2018$97m
2017$116m
2016$67m
2015$83m
2014$115m
2013$0m